(Q51560845)

7 April 2018

editorial

0 references

title

Abatacept for systemic lupus erythematosus: the outlook. (English)

1 reference

7 April 2018

systemic lupus erythematosus

main subject

0 references

author name string

Chi Chiu Mok

series ordinal

1

1 reference

7 April 2018

language of work or name

English

0 references

publication date

4 September 2012

1 reference

7 April 2018

Expert Opinion on Biological Therapy

published in

1 reference

7 April 2018

volume

12

1 reference

7 April 2018

issue

12

1 reference

7 April 2018

page(s)

1559-1561

1 reference

7 April 2018

Treatment of murine lupus with CTLA4Ig

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.721773

Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.721773

CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.721773

The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.721773

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.721773

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.721773

CTLA4Ig alters the course of autoimmune disease development in Lyn-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.721773

Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.721773

10.1517/14712598.2012.721773

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018